Bridging the Gap Between Participants and Clinical Trials
I7P-MC-DSAF: Moderate to Severe Hidradenitis Suppurativa
CONDITION
Skin
GENDER
All
AGE GROUP
From 18
to 75 years
STATUS
Active, not recruiting
A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Eltrekibart in Adult Participants with Moderate to Severe Hidradenitis Suppurativa
Studies Contact Form
Approved By: Bellberry limited
Clinical Trial Registry Link:
Notice: Function WP_Scripts::add was called incorrectly. The script with the handle "gforms_recaptcha_frontend" was enqueued with dependencies that are not registered: gforms_recaptcha_recaptcha. Please see Debugging in WordPress for more information. (This message was added in version 6.9.1.) in /srv/users/australianclinicaltrials/apps/australianclinicaltrials/public/wp-includes/functions.php on line 6260